Cargando…
Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?
Diffusion-weighted magnetic resonance imaging (DWI) is increasingly being used to assess tumour response to a variety of anticancer treatments. The technique is quick to perform without the need for administration of exogenous contrast medium, and enables the apparent diffusion coefficient (ADC) of...
Autores principales: | Afaq, A., Andreou, A., Koh, D.M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-Med
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967137/ https://www.ncbi.nlm.nih.gov/pubmed/20880779 http://dx.doi.org/10.1102/1470-7330.2010.9032 |
Ejemplares similares
-
Whole-body diffusion-weighted imaging in lymphoma
por: Lin, C., et al.
Publicado: (2010) -
Imaging in clinical trials
por: Murphy, P., et al.
Publicado: (2010) -
Diffusion weighted imaging and diffusion kurtosis imaging in abdominal oncological setting: why and when
por: Granata, Vincenza, et al.
Publicado: (2022) -
PET/CT and breast cancer
por: Hegarty, C., et al.
Publicado: (2010) -
Staging cancer of the pancreas
por: Morana, G., et al.
Publicado: (2010)